Skip to content
Fall Sale 40% off everything Ends in Offer ends November 30.

Retatrutide 30 mg: Janoshik Analytical Report #136394

Research use only. StarBio products are supplied strictly for in-vitro laboratory research by qualified professionals. They are not for human or veterinary use, not for diagnostic or therapeutic use, and have not been evaluated by the FDA. This page covers documentation only.

Janoshik Analytical analysed a sample of Retatrutide 30 mg for StarBio and issued report #136394, dated Apr 22, 2026. This page records what that report states. It describes one batch at one point in time.

Report summary

Compound and size tested Retatrutide 30 mg
Laboratory Janoshik Analytical
Report reference #136394
Tested Apr 22, 2026
HPLC purity 99.86%
Labelled amount 30 mg
Measured content 32.02 mg

The report

The laboratory publishes this report on its own website: open report #136394 at Janoshik Analytical. Comparing that page with the figures above is the check that matters. The steps are in how to verify a Janoshik or Medutest report.

What the figures mean

An HPLC purity of 99.86% means that 99.86% of what the detector registered was one component. It is a statement about composition, not about quantity: water and counter-ions are not seen by this test. The distinction is explained in what 99% purity means.

The laboratory also measured the amount in the vial: 32.02 mg against a label of 30 mg. Measured content answers how much is present, which a purity percentage cannot. See net peptide content.

Other reports for GLP-3 (RT)

Across the 2 reports on file with a purity figure, reported HPLC purity runs from 98.87% to 99.86%.

Is your vial from this batch?

Not necessarily. StarBio labels do not carry a lot number, so the link between a vial and its batch is kept against the order. The certificate request form returns the record for the batch your order was filled from. More in matching a vial to its certificate.

Product page: GLP-3 (RT). All reports: COA library.

For laboratory research use only. Not for human or veterinary use.

Questions about this report

What does Janoshik Analytical report #136394 show for Retatrutide 30 mg?

Janoshik Analytical measured 99.86% purity by HPLC and a content of 32.02 mg against 30 mg labelled for Retatrutide 30 mg, tested Apr 22, 2026. Identity was confirmed by mass spectrometry. The report describes one batch at one point in time.

How can I verify Janoshik Analytical report #136394?

Enter the report number on janoshik.com, or open the laboratory record. The report number, compound and date must match the certificate supplied with the order. Testing is done by Janoshik Analytical, not by StarBio or its suppliers.

Does this report cover every GLP-3 (RT) vial StarBio sells?

No. It describes the Retatrutide 30 mg batch it was issued for. Later batches get their own report, listed in the lot history on the GLP-3 (RT) product page. The certificate matched to a specific order is available with the order number through the contact form.

StarBio

Researcher verification

StarBio supplies research compounds only to qualified researchers and laboratories, for in vitro laboratory use. Enter your date of birth and confirm your research use to continue.

You must be 21 or older.

By continuing you affirm that the date and statement above are true. Products are supplied for laboratory research only: not for human or veterinary use, not for diagnostic procedures, and not evaluated by the U.S. Food and Drug Administration. Full disclaimer.

Not a researcher? Exit